← Leaderboards
Lukas Chavez
University Of California, San Diego
$3,360,382
Attributed
$3,360,382
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $770.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,360,382 · 4
By mechanism
R01$1,914,963 · 1
R21$1,445,419 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Vineet Bafna$12,170,956
- Joyce Tran$178,977
- Rowan Saloner$317,670
- Anand Sitaram$102,496
- Kaitlin B Casaletto$10,995,555
Others in their field
Other Emerging Leaders on “Molecular”
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,360,557
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$109,548,439
- Leonard Freedmand · Leidos Biomedical Research, Inc.$85,594,314
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Scott Hensley · University Of Pennsylvania$41,662,743
Research focus
MolecularVariantGenesMediatingTumorSubgroupPublic HealthPrimary NeoplasmRelapseOncogenesInnovationMissionGenetic TranscriptionMalignant NeoplasmsPatient Derived Xenograft ModelCancer PatientEnhancersExperimental StudyCellsGenome SequencingBiologicalNeoplasm MetastasisCohortChild
Grant awards (10)
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma$636,772
R01 · FY2025 · NS · contact PI
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma$617,669
R01 · FY2024 · NS · contact PI
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma$660,522
R01 · FY2023 · NS · contact PI
Transcriptional activation of RCOR2 as a novel oncogenic mechanism in supratentorial ependymoma$536,250
R21 · FY2022 · NS · contact PI
Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma$195,948
R21 · FY2022 · NS · contact PI
Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma$38,732
R21 · FY2022 · NS · contact PI
Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma$236,563
R21 · FY2021 · NS · contact PI
Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations$179,690
R21 · FY2021 · NS · contact PI
Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations$21,986
R21 · FY2021 · NS · contact PI
Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations$236,250
R21 · FY2020 · NS · contact PI